TAT-cyclo-CLLFVY
Tocris Bioscience | Catalog # 5582
Product Description
TAT-cyclo-CLLFVY is a selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50 = 1.3 μM). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. Also reduces tubularization of hypoxic HUVECs.
Product Specifications for TAT-cyclo-CLLFVY
Molecular Weight
Formula
Storage
Purity
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solubility | Soluble to 1mg/ml in water |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 7 publications citing the usage of this product.
- Miranda A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. J.Am.Chem.Soc. 2013 PMID: 23796364
Product Documents for TAT-cyclo-CLLFVY
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for TAT-cyclo-CLLFVY
For research use only
Related Research Areas
Citations for TAT-cyclo-CLLFVY
Customer Reviews for TAT-cyclo-CLLFVY
There are currently no reviews for this product. Be the first to review TAT-cyclo-CLLFVY and earn rewards!
Have you used TAT-cyclo-CLLFVY?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review